Company Analysis Omega Healthcare Investors
1. Summary
Advantages
- Dividends (7%) are higher than the sector average (3.3%).
- The stock's return over the last year (-4.56%) is higher than the sector average (-15.98%).
- The company's current efficiency (ROE=10.02%) is higher than the sector average (ROE=1.96%)
Disadvantages
- Price (37.07 $) is higher than fair price (20.21 $)
- Current debt level 48.89% has increased over 5 years from 1.28%.
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| Omega Healthcare Investors | Real Estate | Index | |
|---|---|---|---|
| 7 days | -0.9% | -4% | -0.1% |
| 90 days | -1.3% | -19.1% | 6.8% |
| 1 year | -4.6% | -16% | 10.9% |
OHI vs Sector: Omega Healthcare Investors has outperformed the "Real Estate" sector by 11.43% over the past year.
OHI vs Market: Omega Healthcare Investors has significantly underperformed the market by -15.45% over the past year.
Stable price: OHI is not significantly more volatile than the rest of the market on "New York Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: OHI with weekly volatility of -0.0876% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (37.07 $) is higher than the fair price (20.21 $).
Price is higher than fair: The current price (37.07 $) is 45.5% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (24.97) is lower than that of the sector as a whole (72.51).
P/E vs Market: The company's P/E (24.97) is lower than that of the market as a whole (62.08).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (2.14) is higher than that of the sector as a whole (-8.76).
P/BV vs Market: The company's P/BV (2.14) is lower than that of the market as a whole (20.84).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (9.65) is higher than that of the sector as a whole (8.19).
P/S vs Market: The company's P/S indicator (9.65) is lower than that of the market as a whole (16.02).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (15.27) is lower than that of the sector as a whole (153.36).
EV/Ebitda vs Market: The company's EV/Ebitda (15.27) is lower than that of the market as a whole (27.1).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 31.01% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (31.01%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-7.74%).
5.4. ROE
ROE vs Sector: The company's ROE (10.02%) is higher than that of the sector as a whole (1.96%).
ROE vs Market: The company's ROE (10.02%) is lower than that of the market as a whole (43%).
5.5. ROA
ROA vs Sector: The company's ROA (4.27%) is higher than that of the sector as a whole (2.97%).
ROA vs Market: The company's ROA (4.27%) is lower than that of the market as a whole (23.28%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (7.18%) is higher than that of the sector as a whole (6.96%).
ROIC vs Market: The company's ROIC (7.18%) is lower than that of the market as a whole (9.2%).
7. Dividends
7.1. Dividend yield vs Market
High yield: The dividend yield of the company 7% is higher than the average for the sector '3.3%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 7% has been steadily paid over the past 7 years, DSI=0.93.
Weak dividend growth: The company's dividend yield 7% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (168.69%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
